Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms.

Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms.

In a previous study, we identified somatic mutations of SF3B1, a gene encoding a core component of RNA splicing machinery, in patients with myelodysplastic syndrome (MDS). Here, we define the clinical significance of these mutations in MDS and myelodysplastic/myeloproliferative neoplasms (MDS/MPN)....

Descrizione completa

Dettagli Bibliografici
Autori principali:	Malcovati, L, Papaemmanuil, E, Bowen, D, Boultwood, J, Della Porta, MG, Pascutto, C, Travaglino, E, Groves, M, Godfrey, A, Ambaglio, I, Gallì, A, Vià, D, Conte, S, Tauro, S, Keenan, N, Hyslop, A, Hinton, J, Mudie, L, Wainscoat, J, Futreal, P, Stratton, MR, Campbell, P, Hellström-Lindberg, E, Cazzola, M
Natura:	Journal article
Lingua:	English
Pubblicazione:	2011

Documenti analoghi

Myelodysplastic/myeloproliferative disorders
di: Luca Malcovati, et al.
Pubblicazione: (2008-01-01)

Somatic mutations of calreticulin in myeloproliferative neoplasms and myelodysplastic/myeloproliferative neoplasms
di: Luca Malcovati, et al.
Pubblicazione: (2014-11-01)

Risk assessment in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms
di: Mario Cazzola
Pubblicazione: (2011-03-01)

Clinical evaluation of extra-hematologic comorbidity in myelodysplastic syndromes: ready-to-wear versus made-to-measure tool
di: Matteo G. Della Porta, et al.
Pubblicazione: (2012-04-01)

Deregulated Gene Expression Pathways in Myelodysplastic Syndrome Hematopoietic Stem Cells
di: Pellagatti, A, et al.
Pubblicazione: (2009)

Clonality in the myelodysplastic syndromes.
di: Boultwood, J, et al.
Pubblicazione: (2001)

Somatic Mutation of SF3B1, a Gene Encoding a Core Component of RNA Splicing Machinery, in Myelodysplasia with Ring Sideroblasts
di: Malcovati, L, et al.
Pubblicazione: (2011)

Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells.
di: Pellagatti, A, et al.
Pubblicazione: (2010)

Molecular basis of myelodysplastic/myeloproliferative neoplasms
di: Andreas Reiter, et al.
Pubblicazione: (2009-12-01)

Identification of Prognostic Markers by Gene Expression Profiling In Myelodysplastic Syndrome Hematopoietic Stem Cells
di: Pellagatti, A, et al.
Pubblicazione: (2010)

Molecular pathogenesis of the myelodysplastic syndromes
di: Boultwood, J, et al.
Pubblicazione: (1999)

Marked down-regulation of nucleophosmin-1 is associated with advanced del(5q) myelodysplastic syndrome.
di: Pellagatti, A, et al.
Pubblicazione: (2011)

Marked down-regulation of nucleophosmin-1 is associated with advanced del(5q) myelodysplastic syndrome
di: Pellagatti, A, et al.
Pubblicazione: (2011)

Neutrophil PRV-1 gene expression in myeloproliferative, myelodysplastic and reactive blood disorders
di: Zhang, J, et al.
Pubblicazione: (2004)

Gene Expression Profiling of CD34(+) Cells in Patients with Myelodysplastic Syndromes
di: Pellagatti, A, et al.
Pubblicazione: (2008)

Risk stratification based on both disease status and extra-hematologic comorbidities in patients with myelodysplastic syndrome
di: Matteo G. Della Porta, et al.
Pubblicazione: (2011-03-01)

Clinical and biological implications of driver mutations in myelodysplastic syndromes.
di: Papaemmanuil, E, et al.
Pubblicazione: (2013)

MYELODYSPLASTIC/MYELOPROLIFERATIVE DISEASES
di: I. N. Subortseva, et al.
Pubblicazione: (2017-01-01)

Telomere length in myelodysplastic syndromes.
di: Boultwood, J, et al.
Pubblicazione: (1995)

Marked downregulation of the granulopoiesis regulator LEF1 is associated with disease progression in the myelodysplastic syndromes.
di: Pellagatti, A, et al.
Pubblicazione: (2009)

Myelodysplastic syndromes
di: Eva Hellström Lindberg
Pubblicazione: (2018-06-01)

Identification of Prognostic Markers by Gene Expression Profiling In Myelodysplastic Syndrome Hematopoietic Stem Cells
di: Pellagatti, A, et al.
Pubblicazione: (2010)

Identification of Prognostic Markers by Gene Expression Profiling In Myelodysplastic Syndrome Hematopoietic Stem Cells
di: Pellagatti, A, et al.
Pubblicazione: (2010)

Frequent Mutation of the Polycomb-Associated Gene ASXL1 in the Myelodysplastic Syndromes and in Acute Myeloid Leukaemia
di: Boultwood, J, et al.
Pubblicazione: (2009)

Impact of the degree of anemia on the outcome of patients with myelodysplastic syndrome and its integration into the WHO classification-based Prognostic Scoring System (WPSS)
di: Luca Malcovati, et al.
Pubblicazione: (2011-10-01)

High Throughput Targeted Gene Sequencing in 738 Myelodysplastic Syndromes Patients Reveals Novel Oncogenic Genes, Rare Driver Mutations and Complex Molecular Signatures with Potential Impact for Patient Diagnosis and Prognosis in the Clinic
di: Papaemmanuil, E, et al.
Pubblicazione: (2012)

Identification of aberrant splicing events in myelodysplastic syndrome patients with splicing factor gene mutations
di: Pellagatti, A, et al.
Pubblicazione: (2017)

Identification of gene expression-based prognostic markers in the hematopoietic stem cells of patients with myelodysplastic syndromes.
di: Pellagatti, A, et al.
Pubblicazione: (2013)

Gene expression profiling in the myelodysplastic syndromes.
di: Pellagatti, A, et al.
Pubblicazione: (2005)

Inappropriately low hepcidin levels in patients with myelodysplastic syndrome carrying a somatic mutation of SF3B1
di: Ilaria Ambaglio, et al.
Pubblicazione: (2013-03-01)

Genome sequencing in the management of myelodysplastic syndromes and related disorders
di: Mario Cazzola, et al.
Pubblicazione: (2024-10-01)

GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR GENE IN MYELODYSPLASTIC SYNDROMES - REPLY
di: Boultwood, J, et al.
Pubblicazione: (1991)

COMPREHENSIVE ANALYSIS OF MUTATION STATUS, GENE EXPRESSION PROFILES, BLOOD AND BONE MARROW COUNTS AND OUTCOME IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES
di: Pellagatti, A, et al.
Pubblicazione: (2014)

Frequent mutation of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemia.
di: Boultwood, J, et al.
Pubblicazione: (2010)

Expression profiling of CD34+cells in patients with myelodysplastic syndromes: differences between early and advanced cases and analysis of apoptosis-related genes
di: Pellagatti, A, et al.
Pubblicazione: (2007)

Comparison and Implications of Mutational Profiles of Myelodysplastic Syndromes, Myeloproliferative Neoplasms, and Myelodysplastic/Myeloproliferative Neoplasms: A Meta-Analysis
di: Ziqi Wan, et al.
Pubblicazione: (2020-10-01)

Expression profiling of CD34+cells in patients with myelodysplastic syndromes with and without a del(5q)
di: Pellagatti, A, et al.
Pubblicazione: (2005)

Genome-wide analysis of copy number change and loss of heterozygosity in myelodysplastic syndrome with del(5q) using high-density SNP arrays
di: Wang, L, et al.
Pubblicazione: (2007)

Examining disease boundaries: Genetics of myelodysplastic/myeloproliferative neoplasms
di: Michael J. Hochman, et al.
Pubblicazione: (2021-08-01)

Myelodysplastic and myeloproliferative diseases in children: current concepts
di: Vyas, P
Pubblicazione: (2014)